Update on postinjury nutrition

Current Opinion in Critical Care

Volumn 14, Issue 6, 2008, Pages 690-695

  Todd, Samuel R ^a   Gonzalez, Ernest A ^b   Turner, Krista ^a   Kozar, Rosemary A ^b,c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Antioxidants; Glutamine; Hypocaloric feeding; Pharmaconutrition

Indexed keywords

ANTIOXIDANT; ARGININE; COPPER; DOCOSAHEXAENOIC ACID; GLUTAMINE; ICOSAPENTAENOIC ACID; NUCLEOTIDE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SELENIUM; ZINC;

ANTIOXIDANT ACTIVITY; BURN PATIENT; CALORIC INTAKE; CLINICAL PRACTICE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG MEGADOSE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INJURY; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NUTRITION; NUTRITIONAL SUPPORT; PATIENT CARE; REVIEW; SEPTIC SHOCK; SUPPLEMENTATION;

ANTIOXIDANTS; ARGININE; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEEDING BEHAVIOR; FOOD, FORMULATED; GLUTAMINE; HUMANS; INFLAMMATION; NUCLEOTIDES; NUTRITIONAL STATUS; TIME FACTORS; WOUNDS AND INJURIES;

EID: 57149113171     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283196562     Document Type: Review

References (54)

1. Moore FA, Moore EE, Jones TN. TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma 1989; 29:916-923.
2. Kudsk KA, Croce MA, Fabian TC, et al. Enteral versus parenteral feeding: effects on septic morbidity following blunt and penetrating abdominal trauma. Ann Surg 1992; 215:503-513.
3. Moore FA, Moore EE, Kudsk KA, et al. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994; 37:607-615.
4. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma: an immune-enhancing diet reduces septic complications. Ann Surg 1996; 224:531-540.
5. Mendez C, Jurkovich GJ, Garcia I, et al. Effects of an immune-enhancing diet in critically injured patients. J Trauma 1997; 42:933-940.
6. Heys SD, Walker LG, Smith I, Eremin O. Enterai nutrition supplementation with key nutrients in patients with critical illness and cancer. Ann Surg 1999; 229:467-477.
7. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27:2799-2805.
8. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in the critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953.
9. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systemic review and analysis of the literature. Intensive Care Med 2008 [Epub ahead of print]. In this meta-analysis, the authors attempt to analyze the benefits of immunonutrition in critically ill patients by formula type. Although this type of analysis is needed, the small number of studies in certain subgroups limits the significance of their findings.
10. Moore FA, Sauaia A, Moore EE, Haenel JB, et al. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996; 40:501-512.
11. Beale RJ, Sherry T, Lei K, et al. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med 2008; 36:131-144. A prospective randomized controlled trial that demonstrated significantly faster recovery of organ function, as measured by Sequential Organ Failure Assessment scores, in medical patients with sepsis who received enteral supplementation with pharmaconutrients.
12. Singleton KD, Wischmeyer PE. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 2007; 292:R1839-R1845. A rodent model of sepsis that confirms glutamine's beneficial effect on survival, injury, and inflammation are dependent upon heat shock protein 70 expression.
13. Ban K, Kozar RA. Enteral glutamine: a novel mediator of PPAR gamma in the postischemic gut. J Leukoc Biol 2008; 84:595-599. A review of laboratory studies in a rodent model demonstrating the protective effects of enteral glutamine by PPAR in the postischemic gut.
14. Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30:2022-2029.
15. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008; 24:215-222. This study provides an excellent overview of the evidence in support of a new paradigm of pharmaconutrition to explain the inconsistent results of immunonutrition.
16. Houdijk AP, Rijnsburger ER, Jansen J, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352:1-6.
17. Garrell D, Patenaude J, Nedelec B, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 2003; 31:2444-2449.
18. McQuiggan M, Kozar R, Sailors RM, et al. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr 2008; 32:28-35. This study is a prospective randomized pilot study that examined the safety and tolerance of enteral glutamine administered to critically injured patients in shock.
19. Barbul A, Lazarou SA, Efron DT. Arginine enhances wound healing and lymphocyte immune response in humans. Surgery 1990; 108:331-336.
20. Salzman AL Nitric oxide in the gut. New Horiz 1995; 3:33-45.
21. Bower RH, Cerra FB, Bershadsky B, et al. Early administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 2001; 23:436-449.
22. Todd SR, Kozar RA, Moore FA. Nutrition support in adult trauma patients. Nutr Clin Pract 2006; 21:421-429.
23. Heyland DK, Samis A. Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med 2003; 29:669-671.
24. Bruzzone R, Radrizzani D. Early enteral immunonutrition in patients with severe sepsis. Results of an interim analysis of a randomized multicenter clinical trial. Intensive Care Med 2003; 29:834-840.
25. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208:512-523.
26. Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 1981; 90:244-251.
27. Ochoa JB, Bernard AC, O'Brien WE, et al. Arginase 1 expression and activity in human mononuclear cells after injury. Ann Surg 2001; 233:393-399.
28. Tsuei BJ, Bernard AC, Barksdale AR, et al. Supplemental enteral arginine is metabolized to ornithine in injured patients. J Surg Res 2004; 123:17-24.
29. Jacob TD, Ochoa JB, Udekwu AO, et al. Nitric oxide production is inhibited in trauma patients. J Trauma 1993; 35:590-597.
30. Sato N, Moore FA, Kone BC, et al. Differential induction of peroxisome proliferator activated receptor gamma by luminal arginine glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol 2006; 290:616-623.
31. Han-Markey T. Nutrient metabolism in children. In: Rolandelli RH, editor. Clinical nutrition enteral and tube feeding, 4th ed. Philadelphia, Pennsylvania: Elsevier Inc; 2005. p. 672.
32. Van Buren CT, Kulkarni A, Fanslow WC, Rudolph FB. Dietary nucleotides, a requirement for helper/inducer T lymphocytes. Transplantation 1985; 40:694-697.
33. Kulkarni AD, Rudolph FB, Van Buren CT. The role of dietary sources of nucleotides in immune function: review. J Nutr 1994; 124 (8 Suppl):1442S-1446S.
34. Aldridge C, Razzak A, Babcock TA, et al. Lipopolysaccharide- stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion. J Surg Res 2008; 149:296-302. This laboratory study demonstrated a reduction in nitric oxide synthase by omega-3 fatty acids following stimulation of macrophages by lipopolysaccharide. A good review of the known molecular mechanisms contributing to the beneficial effect of omega-3 fatty acids.
35. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34:1033-1038.
36. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34:2325-2333.
37. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respirator distress syndrome. Enterai Nutrition in ARDS Study Group. Crit Care Med 1999; 27:1409-1420.
38. Heyland DK, Dhaliwal R, Day AG, et al. REducing Deaths due to OXidative Stress (The REDOX Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006; 65:250-261.
39. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236:814-822.
40. Berger MM, Soquel L, Shenkin A, et al. Influence of early antioxidant supplementations on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Grit Care 2008; 14:R101. A prospective randomized trial of patients in organ failure who received parenteral antioxidants for 5 days, with an initial double-loading dose. The lack of improvement in organ failure may be related to timing and dosing of the antioxidants.
41. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998; 68:365-371.
42. Forceville X, Laviolle B, Annane D, et al. Effects of high-doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 2007; 11:R73. A prospective randomized phase II trial in severe septic shock patients receiving a 9-day infusion of selenium. No toxicity as well as no improvement in clinical outcomes was demonstrated.
43. Collier BR, Giladi A, Dossett LA, et al. Impact of high-dose antioxidants on outcomes in acutely injured patients. JPEN J Parenter Enterai Nutr 2008; 32:384-388. This retrospective cohort study demonstrated a significant reduction in mortality in acutely injured patients receiving high-dose antioxidants (vitamin C and E and selenium).
44. Heyland DK, Dhaliwal R, Suchner U, et al. Antioxidant nutrients: a systematic review of vitamins and trace elements in the critically ill patient. Intensive Care Med 2005; 31:327-337.
45. Angstwurm MW, Engelmann L, Zimmermann T, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35:118-126. This prospective trial administered a 14-day course of parenteral selenium to patients with severe systemic response syndrome, sepsis, and severe sepsis. The intent to treat group had no significant reduction in mortality, the primary endpoint. After over 20% of patients were excluded, coagulopathic patients with severe sepsis and patients with high APACHE III scores (≥102) demonstrated a reduced mortality.
46. Raymond MP. The importance of selenium to human health. Lancet 2000; 356:233-241.
47. Heyland DK. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? Crit Care 2007; 11:153. This commentary explains how an upset in the fine balance between proinflammation and anti-inflammation by the antioxidant, selenium, can be detrimental.
48. Heyland DK, Dhaliwalm R, Day A, et al. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. J Parenter Enterai Nutr 2007; 31:109-118. Results of a phase I dose-escalating clinical trial of glutamine, selenium, or both in mechanically ventilated patients with clinical evidence of hypoperfusion. The doses utilized were well tolerated and provided the framework for the ongoing phase III trial examining mortality benefit.
49. Miller JP, Choban PS. Feeding the critically ill obese patient: the role of hypocaloric nutrition support. Respir Care Clin N Am 2006; 12:593-601.
50. Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition 2002; 18:241-246.
51. Krishnan JA, Parce PB, Martinez A, et al. Caloric intake in the medical ICU patients. Chest 2003; 124:297-305.
52. Ibrahim EH, Mehringer L, Prentice D, et al. Early vs late enterai feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002; 26:174-181.
53. Spindler-Vesel A, Bengmark S, Vouk I, et al. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr 2007; 31:119-126. A prospective study in trauma patients receiving supplemental synbiotics, prebiotics, glutamine or peptides. No difference in ventilator days, ICU length of stay, or multiple organ failure scores were demonstrated. A reduction in infections was seen in the symbiotic group but only when all other groups were combined. The small sample size of the study limits meaningful conclusions.
54. Ash JL, Gervasio JM, Zaloga GP, Rodman GH. Does the quantity of enteral nutrition affect outcomes in critically ill trauma patients? JPEN J Parenter Enteral Nutr 2005; 29:310.